Australia: Market surges to five-month high

Image
Capital Market
Last Updated : Nov 11 2022 | 2:31 PM IST
Australia stock market finished session at five-month high on Friday, 11 November 2022, joining a global rally, amid bottom fishing across the board on tracking an overnight surge on Wall Street on spurring hopes that the Federal Reserve might scale down the size of its future interest rate increases after cooler-than-expected U.S. inflation data in October.

At closing bell, the benchmark S&P/ASX200 index was up 193.94 points, or 2.78%, to 7,157.95, a highest in five months. The broader All Ordinaries index advanced 204.41 points, or 2.86%, to 7,350.10.

Total 10 of 11 sectors ended down, with information technology (up 5%) sector was outperformed, followed by property trusts 9up 4.1%), materials (up 3.7%), healthcare (up 3.6%), and consumer discretionary (up 3.5%), while utilities (down 0.5%) sector was worst performer.

The top performing stocks in S&P/ASX200 index were MEGAPORT and PINNACLE INVESTMENT MANAGEMENT GROUP, up 13.6% and 12.5% respectively. The bottom performing stocks in S&P/ASX200 index were Whitehaven Coal and Origin Energy, down 3.5% and 3.1% respectively.

Overnight on Wall Street, U.S. stocks jumped as consumer prices rose less than expected in October, pushing the annual increase below 8% for the first time in eight months, the strongest signs yet that inflation was slowing.

Back to home, materials stocks advanced as iron ore prices jumped after China stressed the need to minimise COVID-19's impact on the economy, raising hopes for a more targeted approach to contain outbreaks. BHP Group, Rio Tinto and Fortescue Metals Group climbed between 3.8% and 5.8%.

Tech stocks advanced on tracking US peers rally, with the ASX-listed shares of Block Inc jumping 11.5%. Financials soared 2.1%, with the "big four" banks gaining between 1.1% and 2%.

Among individual companies, Nine Entertainment shares advanced 4% after the media company secured a deal with Tennis Australia to broadcast The Australian Open and other local tournaments until 2029.

Resonance Health shares rose 8% after medical device maker announced it secured two new services contracts for its liver-iron concentration measuring devices, Ferriscan and Cardiac T2, for use in two separate clinical trials.

Ramsay Health Care jumped 5.8% after the country's largest private hospital operator issued optimistic outlook for 2023 and 2024 fiscal years.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 11 2022 | 2:06 PM IST

Next Story